Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
Clinical trial NCT03872232 · COMPLETED
Trial details
- NCT number
- NCT03872232
- Sponsor
- Addpharma Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-26
- Primary completion
- 2020-08-12
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.